<p>Clinical statistics of the time frame of ALS-like symptoms with corresponding treatment doses.</p
<p>For each tertile group, mean age is indicated below survival time mean value.</p
<p>Demographics and clinical features of the Irish, Italian and French ALS population cohorts and th...
<p>ALS<12 m: the time from ALS onset to diagnosis was less than 12 months; AL≥12 m: the time from AL...
<p>Correlations between clinical outcomes and metabolites/metabolite ratios in ALS.</p
a<p>Progression rate = (40-ALSFRS)/disease duration (months).</p>b<p>ALSFRS-ALS functional rating sc...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
To determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defin...
<p>Descriptive statistics for all estimated cost variables (rounded to nearest dollar) and cumulativ...
An ecological study about the space-time distribution of the ALS incidence cases by onset type in th...
Descriptive statistics of the treatment frequencies per year of the different age groups for differe...
<p>Abbreviations: PMA = progressive muscular atrophy, ALS = amyotrophic lateral sclerosis, N = numbe...
<p>Performance on ACCT subtests in ALS patients and healthy subjects. Data are expressed as Means (S...
<p>Correlations between (a, left) ALSFRS-R bulbar subscore (/12) and articulatory rate (SPM); and (b...
*<p>Possible ALS used as baseline category for El-Escorial category rate ratio calculations.</p>‡<p>...
<p>For each tertile group, mean age is indicated below survival time mean value.</p
<p>Demographics and clinical features of the Irish, Italian and French ALS population cohorts and th...
<p>ALS<12 m: the time from ALS onset to diagnosis was less than 12 months; AL≥12 m: the time from AL...
<p>Correlations between clinical outcomes and metabolites/metabolite ratios in ALS.</p
a<p>Progression rate = (40-ALSFRS)/disease duration (months).</p>b<p>ALSFRS-ALS functional rating sc...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
To determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defin...
<p>Descriptive statistics for all estimated cost variables (rounded to nearest dollar) and cumulativ...
An ecological study about the space-time distribution of the ALS incidence cases by onset type in th...
Descriptive statistics of the treatment frequencies per year of the different age groups for differe...
<p>Abbreviations: PMA = progressive muscular atrophy, ALS = amyotrophic lateral sclerosis, N = numbe...
<p>Performance on ACCT subtests in ALS patients and healthy subjects. Data are expressed as Means (S...
<p>Correlations between (a, left) ALSFRS-R bulbar subscore (/12) and articulatory rate (SPM); and (b...
*<p>Possible ALS used as baseline category for El-Escorial category rate ratio calculations.</p>‡<p>...
<p>For each tertile group, mean age is indicated below survival time mean value.</p
<p>Demographics and clinical features of the Irish, Italian and French ALS population cohorts and th...
<p>ALS<12 m: the time from ALS onset to diagnosis was less than 12 months; AL≥12 m: the time from AL...
DOI
Add to ORKG